Artificial Intelligence

Berlin-based Tacalyx is advancing its lead drug, TCX-201, to the clinic, targeting a novel class of antigens once thought impossible to drug.

At SynBioBeta 2026, Ansa Biotechnologies unveils a bold on-time guarantee, challenging rivals and promising to accelerate research with its advanced DNA tech.

A new report reveals that while Americans value mental health more than ever, financial stress, gender gaps, and system barriers are widening the divide.

Major League Soccer selects five AI startups for its Innovation Lab, aiming to transform player health, fan experience, and media ahead of the 2026 World Cup.

With a major bank live and over $60M in VC funding, Valstro's AI-native platform aims to disrupt the legacy systems dominating sell-side trading.

Tecnotree posts robust Q1 profits and a record €105.4M order book, but geopolitical tensions squeeze cash flow, testing its AI-powered resilience.

EY and Rillet partner on an AI-native finance platform, promising modernization without disruption and embedding risk controls from the very start.

With revenues up 18.8% and orders surging 110%, STL is leveraging its advanced fiber tech to become a key player in the booming AI data centre market.

The new platform unifies AI agents, telephony, email, and quoting, offering independent agencies a single, compliant, autonomous operating system.

Seven CCRM clinics named best in the nation, showcasing how a unique, science-first approach is setting a new standard in reproductive medicine.

Omnicell appoints Rick Couldry as its first Chief Pharmacy Officer, a strategic move to embed 30 years of real-world hospital experience into its tech.

As DLH Holdings prepares its Q2 results, investors watch to see if it can navigate contract losses and prove its mettle in the federal tech space.

The Defense Logistics Agency has awarded a landmark $50M contract to Corsha to rapidly deploy identity-based Zero Trust security across its critical OT systems.

GD Culture Group launches 'Fato', an AI-powered interactive novel, in a bold pivot. Can it disrupt a growing market or will it be lost in the hype?

With patient enrollment accelerating for its novel lung fibrosis drug, LTI-03, Rein Therapeutics signals progress in a field desperate for new options.

Beyond dashboards: Chord secures $7M to expand its AI that actively runs e-commerce, backed by the founders of Glossier and major brands like Mr. Beast.

As AI-driven attacks breach networks in minutes, a new certification highlights the urgent need to secure the forgotten frontier: internal 'east-west' traffic.

With Jack Dorsey's backing, new app Divine resurrects Vine's spirit on a decentralized, AI-free platform. Can nostalgia challenge TikTok's dominance?

Alibaba's Accio Work deploys AI "business teams" to SMEs, managing e-commerce and even launching physical products from scratch for a new era of business.

A modest 0.4% Q1 gain for Canadian pensions masks a dramatic story of geopolitical shocks, a booming energy sector, and a deep tech selloff.